Medicinal Chemistry Project Leader Remote, Hybrid, Haven - CT

Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non‑small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non‑Hodgkin Lymphoma; ARV-027, targeting the polyglutamine‑expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy;

and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2‑ breast cancer.

Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first‑ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out‑licensed for commercialization and further development.

#Team Arvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform.

We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say .

Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit  and connect on Linked In and X .

The Medicinal Chemistry Project Leader is expected to lead the chemistry efforts as part of a cross‑functional project team to drive programs to key decisions at all stages of the preclinical pipeline. This role requires deep understanding and utilization of key concepts in medicinal chemistry to design molecules with optimized potency, selectivity and pharmacokinetic properties, with a particular emphasis on degrader‑antibody conjugates.

This role reports to the Executive Director, Medicinal Chemistry. This work can be performed on‑site at our headquarters in New Haven, CT with hybrid work arrangements being available, depending on work requirements and project needs.

• Drive milestone decision‑making on assigned PROTAC projects, which may focus on degrader‑antibody conjugates, from inception to clinical candidate nomination in line with target product profiles and timelines within a team environment
• Expeditious molecular and synthetic design of PROTACs, degrader‑antibody conjugates, and libraries in conjunction with state‑of‑the‑art computational chemistry resources to enable program advancement
• SAR analysis of complex, multivariate datasets to generate new testable hypotheses
• Dynamic interaction with external CRO resources to ensure synthetic and data needs are fulfilled according to agreed timelines and standards
• Solicitati…